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The nervous system inﬂuences organ development by direct innervation and the action of
hormones. We recently showed that the speciﬁc absence of Rac1 in neurons (Rac1
N)i na
Rac3-deﬁcient (Rac3
KO) background causes motor behavioural defects, epilepsy, and
premature mouse death around postnatal day 13. We report here that Rac1
N/Rac3
KO mice
display a progressive loss of immune-competence. Comparative longitudinal analysis of
lymphoid organs from control, single Rac1
N or Rac3
KO, and double Rac1
N/Rac3
KO mutant
animals showed that thymus development is preserved up to postnatal day 9 in all animals,
but is impaired in Rac1
N/Rac3
KO mice at later times. This is evidenced by a drastic reduction
in thymic cell numbers. Cell numbers were also reduced in the spleen, leading to splenic
tissue disarray. Organ involution occurs in spite of unaltered thymocyte and lymphocyte
subset composition, and proper mature T-cell responses to polyclonal stimuli in vitro.
Suboptimal thymus innervation by tau-positive neuronal terminals possibly explains the
suboptimal thymic output and arrested thymic development, which is accompanied by
higher apoptotic rates. Our results support a role for neuronal Rac1 and Rac3 in dictating
proper lymphoid organ development, and suggest the existence of lymphoid-extrinsic
mechanisms linking neural defects to the loss of immune-competence.
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Introduction
Over the past several years complex bidirectional interactions
between the nervous system and the immune system have been
identiﬁed, which seem necessary to maintain homeostasis in both
systems and to regulate the immune response. Sympathetic
innervation of lymphoid organs is involved in the control of the
immune responses [1]. In particular, the central nervous system
may inﬂuence immune cell function by the sympathetic nerve
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can bind to adrenergic receptors expressed by various cell types in
the lymphoid organs [2]. The close proximity of sympathetic nerve
terminals to immune cells provides a mechanism for the speciﬁc
targeting of catecholamines to immune cells [3, 4]. On the other
hand, little is known about the role of, and the molecular
mechanisms underlying, the innervation of the immune system.
Rac GTPases are members of the Rho family, which positively
regulate the dynamics of the actin cytoskeleton, thus affecting
cell morphology and development [5]. It is known that the
endogenous Rac GTPases speciﬁcally expressed in each organ
play important functions in the development of the neural and
immune system respectively [6–8]. Speciﬁcally, two of the three
mammalian Rac GTPases are expressed in the immune system:
the ubiquitous Rac1 and the hematopoietic-speciﬁc Rac2 proteins
[9, 10]. On the other hand, the neural-speciﬁc Rac3/Rac1B GTPase
is co-expressed with Rac1 in the nervous system [11, 12], while it
is undetectable in the lymphoid organs [13]. We have generated a
number of KO mice in which either one or both Rac1 and Rac3
genes have been deleted during neuronal development [14]. These
mice include the full deletion of the neural-speciﬁc gene for Rac3
(Rac3
KO), and the conditional neuronal deletion of the gene for
Rac1 by the Synapsin-Cre transgene (Rac1
N). While single Rac3
KO
or Rac1
N mutant mice do not show evident phenotypes and
develop normally, Rac1
N/Rac3
KO double mutant mice are neuro-
logically impaired, and die around P13 (postnatal day 13), with
identiﬁable speciﬁc defects in the development of the brain [14].
In this study, we have addressed the indirect effects of the
deletion of the neuronal Rac proteins on the development of the
immune system. We found that the simultaneous inactivation of
neuronal Rac1 and Rac3 causes speciﬁc defects in the development
of the spleen and thymus of the Rac1
N/Rac3
KO double KO mice,
and a concomitant defect in the innervation of the thymus of
Rac1
N/Rac3
KO mice. Our results show for the ﬁrst time that the
impairment of speciﬁc molecular mechanisms underlying neuronal
development has striking effects on the development of the immune
system, and support the notion of a direct important implication of
innervation on the development of the lymphoid organs.
Results
Neuronal deletion of Rac1 and Rac3 impacts on
lymphoid organ development
Rac1
N/Rac3
KO double-deﬁcient mice have abnormal postnatal
development with severe runting and death by 2wk of age [14].
By P13 Rac1
N/Rac3
KO double KO mice show clear neurological
symptoms [14], are smaller than control littermates (data not
shown), and reveal a lower body weight (Fig. 1A). We noticed
that by this time, the size (Fig. 1B and D) and the cellularity
(Fig. 1C and E) of the thymus and the spleen were severely
reduced in the double-mutant mice with respect to Rac3
KO
littermates (Fig. 1B and D) and to Rac1
N and WT mice (data not
shown). Accordingly, the total numbers of thymocytes and
splenocytes in Rac1
N/Rac3
KO double KO mice were also
decreased when compared with WT, Rac1
N, and Rac3
KO
littermates (Fig. 1C and E). In contrast, the cellularity of
peripheral lymph nodes was comparable in double KO and
control littermates (Supporting Information Fig. 1). To better
understand this phenomenon we performed longitudinal
analyses. Mice were sacriﬁced at P4, P7, P9, and P13 and organ
cellularity was assessed by viable counts. While thymic growth
was comparable up to P9 in all the mice and continued to grow in
WT, Rac1
N, and Rac3
KO littermates, thymic involution was found
by P13 in Rac1
N/Rac3
KO double-mutant mice (Fig. 2A). In the
case of the spleen (Fig. 2B), differences were already evident by
P9, a time at which both neurological manifestation and reduced
body weight are already evident [14].
With the aim of deﬁning the immunophenotype of Rac1
N/
Rac3
KO mice, primary and secondary lymphoid organs were
examined by ﬂow cytometric analysis using lineage-speciﬁc
markers during disease progression at P13, a time at which the
cellularity of both thymus and spleen is decreased in Rac1
N/
Rac3
KO mice. The relative distribution of CD4
CD8
 double
negative (DN) cells and subsets (identiﬁed by the relative
expression of CD44 and CD25, data not shown), CD4
1CD8
1
double positive, and CD4
1 or CD8
1 single-positive thymocytes
was comparable in WT, Rac1
N, Rac3
KO, and double-mutant mice
at P13 (Fig. 3). Similar results were obtained at P9 (Supporting
Information Table 1). In spite of the fact that the relative repre-
sentation of thymocyte precursor was mostly preserved, as a
consequence of overall decreased cellularity (Fig. 1C and E), the
total numbers of all major subsets were reduced in Rac1
N/Rac3
KO
double KO mice when compared with WT, Rac1
N, and Rac3
KO
littermates (data not shown). This might suggest that thymic
defects could not be ascribed to a speciﬁc developmental arrest
but rather to a general defect of organ function.
At P13, CD4 and CD8 mature T cells were found to be slightly
enriched in frequencies in the spleen of double-mutant mice
when compared with WT mice, Rac1
N, and Rac3
KO littermates
(Fig. 4A–C), although reduced in total number as a consequence
of defective cellularity of the organ at this time (Fig. 1E). Also
the frequency of mature B220
1 cells was found to be normal
(Fig. 4D), while their total numbers were lower in Rac1
N/Rac3
KO
double KO mice when compared with WT, Rac1
N, and Rac3
KO
littermates (data not shown). This was in spite of their normal
representation in the BM, which revealed comparable frequencies
of eritroid, myeloid, and hematopoietic cells in WT and mutant
mice (Supporting Information Fig. 2). We next investigated the
histological appearance of cryo-preserved P13 tissue sections.
The general architecture of the thymus was preserved in Rac1
N/
Rac3
KO with proper cortico-medullary differentiation. Immuno-
staining of stromal components indicated that both mTEC
(cytokeratin 5; CK5
1) and cTEC (CK8
1) were correctly posi-
tioned. Similarly, immunoreactivity for claudin-4, detecting
mature mTEC, was comparable (Supporting Information Fig. 3).
Immature thymocytes, identiﬁed by the TdT, were also found to
be correctly positioned and mostly distributed within cortical
region with only rare TdT
1 cells present within the medulla of
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KO and Rac1
N/Rac3
KO (Supporting Information Fig. 3).
Although IL-7, a nonredundant trophic factor for immune cell
development [15], was expressed in both Rac3
KO and Rac1
N/
Rac3
KO thymi (Supporting Information Fig. 4A), variability
among independent experiments failed to overrule a possible
defect along this pathway in mutant mice. Against this possibility,
DN thymocytes proliferated to comparable extents in short BrdU-
pulse experiments in vivo (Supporting Information Fig. 4C). In
some of the Rac1
N/Rac3
KO sections the cortical region appeared
to contain fewer CD3
1 precursors, which instead appeared better
represented within the more densely populated medullary region.
Also, Foxp3
1 cells, identifying T-regulatory cells exclusively
present in the thymic medulla, were better represented in
Rac1
N/Rac3
KO when compared with Rac3
KO mice (Supporting
Information Fig. 3). Histological analysis of the spleen revealed
an altered red/white pulp ratio in Rac1
N/Rac3
KO, possibly
reﬂecting the lower numbers of T and B cells, major constituents
of the white pulp (Supporting Information Fig. 5A and B).
In addition to the thymus and the spleen, the size (data not
shown) and weight (Supporting Information Fig. 6A) of other
organs including kidney, heart, and liver were also signiﬁcantly
smaller in P13 double KO animals when compared with Rac3
KO
littermates. In contrast, the size and weight of the brain [14] and
the lung (Supporting Information Fig. 6A) were comparable in
Rac3
KO and Rac1
N/Rac3
KO mice. In all cases, the histological
appearance of non-lymphoid tissues of Rac1
N/Rac3
KO mice
appeared normal (Supporting Information Fig. 6B).
Together these data indicate that the manifestation of
neurological symptoms inﬂuences the development/growth of
several vital organs to different extents, severely hindering
immune-competence in Rac1
N/Rac3
KO double-mutant mice.
Neuronal depletion of Rac1 and Rac3 is responsible for
the effects observed on lymphoid organs
Rac1
N/Rac3
KO mice carry the full deletion of the neural-speciﬁc
gene for Rac3 (Rac3
KO), and the conditional neuronal deletion of
the gene for Rac1 by the Synapsin-Cre transgene (Rac1
N). We
reasoned that the developmental defects observed in the spleen
and thymus of Rac1
N/Rac3
KO mutant mice was not attributable
to a defect of endogenous Rac function in these organs. To better
Figure 1. Rac1
N/Rac3
KO double-deﬁcient mice exhibit reduced size and cellullarity of primary and secondary lymphoid organs. WT, Rac1
N, Rac3
KO,
and Rac1
N/Rac3
KO mice were sacriﬁced at P13. (A) Body weight of P13 mice. (B and D) Representative (B) thymi and (D) spleens from Rac3
KO and
Rac1
N/Rac3
KO. (C and E) Thymi and spleens were explanted and reduced to single-cell suspensions. Total numbers of viable cells in the (C) thymus
and (E) spleen were obtained by (A, C, and E) Trypan blue counts. Each symbol represents data from an individual mouse; horizontal bar represents
the mean. p o 0.005; p o 0.001 by one-way ANOVA with Bonferroni correction.
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expressed in the thymus and spleen by immunoblots. While
Rac3 was readily immunoprecipitable from brain extracts, it
remained undetectable in thymus and spleen extracts of both WT
and Rac1
N mice (Fig. 5A and B). Furthermore, Rac levels were
unchanged in the thymus of Rac1
N with respect to WT mice
(Fig. 5B), supporting preserved Rac representation in the
lymphoid compartment of Rac1
N/Rac3
KO mutant mice. Thus,
the ﬁnding that Rac3 is not expressed in the thymus and spleen,
together with the observation that lymphoid organ aplasia was
only found after full deletion of Rac3 and neuronal deletion of
Rac1 strengthens the notion that rather than a defect intrinsic to
the lymphoid tissues, an extrinsic mechanism was responsible for
the observed impairment of the immunocompetence.
To further understand whether neuronal depletion of Rac1
and Rac3 had an impact on mature T-cell function, we char-
acterized their surface and functional phenotype. In spite of the
observed peripheral lymphopenia, central (CD44
highCD62L
high)
and effector (CD44
highCD62L
low) memory cells were equally
represented among CD4
1 (Fig. 6A) and CD8
1 (data not shown)
T cells derived from Rac1
N/Rac3
KO and Rac3
KO littermates. Most
T lymphocytes maintained a naı ¨ve CD44
lowCD62L
high phenotype
(Fig. 5A), proper expression of CD127 (Supporting Information
Fig. 4B), and a low rate of cell division in short BrdU-pulse
experiments in vivo (Supporting Information Fig. 4D). Further-
more, ﬂow cytometry CFSE dilution assays revealed that CD4
1
(Fig. 6B) and CD8
1 (data not shown) T cells from Rac1
N/Rac3
KO
and Rac3
KO littermates proliferated to a similar extent after
polyclonal CD3/CD28-driven stimulation in vitro. These results
support the existence of extrinsic rather than cell autonomous
defects.
Axonal thymic innervation is suboptimal in Rac1
N/
Rac3
KO double KO mice at P13
Progressive loss in cellularity in the thymus and the spleen of
Rac1
N/Rac3
KO mice was accompanied by an increased rate of
apoptosis, revealed by immunohistochemistry with anti-cleaved
caspase 3 mAb, both in the thymus cortex and medulla (Fig. 7),
and in the spleen (Supporting Information Fig. 5C). As
progressive loss of immunocompetence parallels the onset of
neurological manifestations, we investigated whether defective
organ innervation might account for the observed phenotype.
Innervation of the thymus by non-myelinated sympathetic and
parasympathetic nerves has been shown to be important for
thymus function and to maintain T-cell maturation. We analysed
the expression in the thymus of tyrosine hydroxylase (TH), a key
enzyme in the synthesis of norepinephrine, which has been used
previously to study axonal endings from sympathetic motor
neurons in the thymic cortex, and associated with thymic
involution in Twitcher mice [16]. We found that at P13, the
density of sympathetic innervation of the thymus was comparable
in Rac1
N/Rac3
KO double mutants and control Rac3
KO mutants,
indicating that a defect at this level might not account for the
observed phenotype (Fig. 8A and Supporting Information Fig. 7).
We also studied cholinergic innervation by immunohistochem-
istry. Unfortunately, while antibodies to choline acetyltransfer-
ase, a marker of cholinergic innervation, revealed speciﬁc signals
on control brain sections, they failed to provide a reliable signal
on thymic sections (data not shown).
In the case of neuroﬁlament, expression in the thymus of
double KO mice was comparable to that of control tissue
(Supporting Information Fig. 8). Antibodies for other neuronal
markers also failed to provide a speciﬁc signal or revealed high
non-speciﬁc background on lymphoid tissue sections (Supporting
Information Fig. 9A and data not shown). In the case of the Tuj1
mAb for b3 tubulin it has been found to be also expressed in
lymphoid cells [17], and only detectable in neuronal terminals in
immunologically mature mice by confocal microscopy [18]. We
thus attempted to address the quantitative expression of neuronal
markers in the thymus by immunoblotting of tissue extracts.
Quantiﬁcation of b3 tubulin did not show any signiﬁcant differ-
ences between the thymi of double KO and control mice
(Supporting Information Fig. 9B). On the other hand, we found
that the microtubule-associated protein tau, a speciﬁc axonal
marker [19], was detectable in the thymus of P13 mice (Fig. 8B).
Speciﬁcally, we observed a signiﬁcant reduction (E40%) of the
major intermediate band (tau-m) recognized by the anti-tau
Figure 2. Thymic development declines after P9 in Rac1
N/Rac3
KO mice.
(A) WT, Rac1
N, Rac3
KO, and Rac1
N/Rac3
KO mice were sacriﬁced at the
indicated postnatal days, and (A) thymocyte and (B) splenocyte
numbers were determined by ﬂow cytometry. Total numbers of viable
cells are depicted. Each symbol represents data from an individual
mouse; horizontal bar represents the mean.
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N/Rac3
KO double KO mice with
respect to control Rac3
KO littermates (Fig. 8C). No signiﬁcant
differences were detected between Rac1
N and WT P13 littermates
when quantiﬁed in independent experiments (Fig. 8B and C).
The decrease of tau in the thymi of double KO mice with
respect to control Rac3
KO mice was evident already at P9 (Fig. 8D
and E). No differences were detectable for either tau or b3
tubulin in the spleen from P13 double KO mice with respect to
controls (Supporting Information Fig. 10). These results indicate
that axonal endings within the thymus are compromised in
Rac1
N/Rac3
KO double-mutant mice, providing a possible causa-
tive link between neuronal perturbation and the observed thymic
deﬁcits.
Discussion
The results from this study show that the speciﬁc neuronal
deletion of the genes for the two GTPases Rac1 and Rac3 hinders
the acquisition of immune-competence, and this can be
explained, at least in part, by defective thymus innervations by
tau-positive neurons.
Rac1
N/Rac3
KO double-deﬁcient mice die by 2wk of age [14].
By P13 Rac1
N/Rac3
KO double KO mice show clear neurological
symptoms [14] and reduced body weight when compared with
control littermates. While brain, lungs, and lymph nodes of
Rac1
N/Rac3
KO double KO were comparable to those of Rac3
KO
mice, kidney, heart, liver, thymus, and the spleen were found to
be smaller in size. Behavioural analysis of the mice (observation)
indicated the absence of nutritional problems. Furthermore,
histological examination of tissue sections revealed normal for
most of the organs, except for the spleen, suggesting that the loss
of immune-competence is not the result of a general metabolic
stress. Results rather indicate that neurological manifestations
might impact the function of several body organs to different
extents, possibly with different kinetics and mechanisms, to
which the lymphoid organs might be most sensitive.
In longitudinal analysis we observed that the thymus and the
spleen progressively enlarged during postnatal life, doubling in
size between P4 and P13 in normal WT mice, in mice lacking
Rac3, or in mice with neuronal speciﬁc inactivation of Rac1. In
contrast, in Rac1
N/Rac3
KO double-mutant mice thymic growth
was normal up to P9 but severely hindered at later times. In the
case of the spleen, but not the peripheral lymph nodes, differ-
ences between Rac1
N/Rac3
KO and control littermates were
evident even at P9. Of note, in addition to T cells, also B cells
were reduced in numbers in Rac1
N/Rac3
KO mice. This was in
spite of proper representation of BM precursors, and rather
reﬂected a peripheral defect evidenced by the disrupted archi-
tecture of the spleen.
Reduced thymic output, together with hindered homeostasis
of mature T (and B) cells caused a profound peripheral
lymphopenia in the double KO animals. Of note, although cells of
maternal origin might contribute to the circulating pool of
mature T cells, their frequency in offspring is generally very low
( o0.1%) [20]. Since double-mutant mice are indistinguishable
from controls up to P7, it seems unlikely that maternal lympho-
cytes account for all circulating cells. In spite of the lymphopenic
environment, most of the CD4
1 and CD8
1 T cells in the periphery
maintained a naı ¨ve phenotype (CD44
low, CD62L
high, CD127
high),
and a very low frequency of cells incorporated BrdU in short
pulse experiments in both double KO and control littermates.
These ﬁndings suggest that proliferation of mature T-cell
precursors, commonly observed in lymphopenic conditions and
known to cause naı ¨ve T cells to acquire a memory phenotype,
does not play a relevant role by this early age of postnatal life.
Thus, the lower T-cell numbers observed in double KO mice have
to be ascribed to extrinsic mechanisms rather than to defects
intrinsic to the lymphocytes. Accordingly, (i) T cells do not
express Rac3, but rely on Rac1 and Rac2 [9, 10] that were not
affected in the lymphoid organs of Rac1
N/Rac3
KO mice;
(ii) T cells derived from Rac1
N/Rac3
KO double-mutant mice were
able to respond to TCR/CD28 stimulation, and to proliferate to
extents comparable to those of WT cells, supporting a preserved
functionality. Accordingly, previous reports indicated that dele-
tion of the Rac1 and Rac2 genes within the lymphoid cells evoked
immune phenotypes that differed from those described here. For
instance, Rac2-deﬁcient mice revealed normal thymocyte
development or positive/negative selection, and only impaired
Figure 3. Thymocyte subset composition is preserved in Rac1
N/Rac3
KO
double KO mice. WT, Rac1
N, Rac3
KO, and Rac1
N/Rac3
KO mice were
sacriﬁced at P13. Thymi were explanted, reduced to single-cell
suspensions, and analysed by ﬂow cytometry after staining with
anti-CD4, CD8 mAbs. (A) Representative dot plots after gating on viable
cells. (B–E) Frequency of (B) CD4/CD8 DN, (C) CD4/CD8 double positive,
and (D) CD4 or (E) CD8 single positive (SP) cells of individual mice. Each
symbol represents data from an individual mouse; horizontal bar
represents the mean. Data were not statistically different by one-way
ANOVA with Bonferroni correction.
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1 generation, and Erk and p38 activa-
tion during T-cell stimulation and Th1 differentiation [21].
Furthermore, mice with hematopoietic-speciﬁc inactivation of
Rac2 developed normally with weight and cellularity of spleens
and thymi similar to those of control mice, and only revealed
defective chemotaxis and superoxide production by neutrophils
[22]. Whereas the absence of either Rac1 or Rac2 alone had no
effect on thymic development, their simultaneous deletion
resulted in a developmental arrest, defective positive selection,
and enrichment of CD4
–CD8
– DN thymocytes [23, 24]. B cell-
lineage-speciﬁc inactivation of Rac1 in a Rac2-deﬁcient back-
ground [25] showed no signiﬁcant changes in the number of pro-,
pre-, and immature B cells, but profound defects in the number of
splenic transitional types 1 and 2 and mature B cells [26]. Thus,
while lymphoid-speciﬁc inactivation of Rac family members
appears to interfere with proper central development and
peripheral mature lymphocyte functions, our data rather indicate
that the effects observed on the immune system are due to the
ablation of Rac GTPases in the neuronal cells. Indeed, in the case
of Rac1
N/Rac3
KO mice, the neuronal deletion of Rac1 and
Rac3 did not cause a speciﬁc arrest at selected stages during
thymic development and did not inﬂuence the ability of
T lymphocytes to proliferate upon receptor engagement, thus
supporting the lack of a T-cell intrinsic defect and rather the
existence of a neuronal deﬁciency, impacting on organ innerva-
tion. Indeed the thymus of double KO mice revealed a decreased
level of the microtubule-stabilizing protein tau, a speciﬁc axonal
marker [19]. Whether decreased innervation by tau
1neurons
might also explain the reduction in size of the spleen and even-
tually of the kidney, heart, and liver with consequences that
might become histologically visible at different times remains to
be determined.
The mechanisms that underlie the possible inﬂuence of
neuronal function on the development of the immune system are
poorly understood. Previous results suggested that the thymus
receives parasympathetic innervations relatively early in onto-
geny, and that nerve ﬁbres could be involved in the regulation of
the organ activity through action upon the thymocytes and/or by
modulation of the thymic vasculature or epithelial cell activity
[27]. Direct innervation [1, 28, 29] as well as the release of
hormones such as somatotrophin [30] have also been previously
shown to exert an inﬂuence on primary and secondary immune
organs, which are highly innervated by non-myelinated sympa-
thetic projections from central motor neurons [31, 32]. We have
shown here that perturbation of the function of neuronal Rac
GTPases during neuronal development has a profound effect on
the development of a functional immune system. To the best of
our knowledge, this is the ﬁrst indication that perturbation of the
machinery directly involved in neurite extension affects the
development of the immune system. Moreover, our ﬁnding that
the thymus of double Rac1/Rac3 mice showed decreased
expression of the axonal protein tau provides support to a
neuronal contribution to the homeostasis of primary lymphoid
organs. In this direction, it has recently been shown that the
degeneration of the autonomic innervation observed in the
Twitcher mouse model for Krabbe disease, a neurological disor-
der characterized by progressive demyelination, is also associated
to thymic atrophy and loss of immune-competence [16],
supporting a crucial role for neuronal function in the regulation
of the functions of lymphoid organs. Progressive involution of the
thymus starting at P9 in Rac1
N/Rac3
KO double-mutant mice
closely resembles that found after P15 in the Twitcher mouse. As
Figure 4. Normal frequencies of mature T and B cells in double KO
mice. WT, Rac1
N, Rac3
KO, and Rac1
N/Rac3
KO mice were sacriﬁced at P13.
Spleens were explanted, reduced to single-cell suspensions, and
analysed by ﬂow cytometry after staining with anti-CD4, CD8 and
B220 mAbs. (A) Representative dot plots after gating on viable cells.
(B–D) Frequency of (B) CD4-, (C) CD8- and (D) B220-expressing cells
expressed as a percentage of total viable cells. Each symbol represents
data from an individual mouse; horizontal bar represents the mean.
p o 0.05; p o 0.005; p o 0.001 by one-way ANOVA with Bonferroni
correction.
Figure 5. Rac3 is not expressed in lymphoid tissues of WT and Rac1
N
mice. WTand Rac1
N mice were sacriﬁced at P7. Protein lysates of brain,
thymus (Thy), and spleen (Spl) from (A and B) WT and (B) Rac1
N mice
were immunoprecipitated with control (IP-C) or anti-Rac3 antibodies
(IP-Rac3). Immunoprecipitates and lysates (200mg) were blotted with an
anti-Rac mAb recognizing both Rac1 and Rac3. Numbers on the left
indicate molecular weight. Data are representative of three indepen-
dent determinations.
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N/Rac3
KO double-mutant mice, Twitcher mutants also
revealed a normal development of thymi and peripheral
lymphoid organs during the initial postnatal life. Thus, progres-
sive loss of immune-competence, best explained by thymic invo-
lution, found at P13 and P30 characterize both the Rac1N/
Rac3
KO and Twitcher mice, respectively, which substantially
differ in causes and manifestation of neurological dysfunctions
but recapitulate similar immunological phenotypes. Of note,
while there is a predominate sympathetic (catecholamine) input
to all components of the immune system, afferent innervation
might be limited to lymph nodes and BM. Thus, differences in
organ innervations, in the relative contributions of Rac1 and
Rac3 to the development of nerve ﬁbres serving distinct organs,
or in innervation of the organ-associated vasculature, might
account for the fact that functionality of spleen and thymus but
not of BM or lymph nodes are impeded during initial postnatal
life. Similarly, the ﬁnding that both the thymus and spleen mainly
beneﬁt from sympathetic nerves, which, however, arise from
different ganglia (from the upper paravertebral ganglia of the
sympathetic chain and the superior mesenteric and celiac gang-
lionic plexuses respectively [33]), might explain the difference in
the timing of symptom manifestation.
Hypoplasia and abnormal maturation of lymphoid organs
have been documented in other diseases, including the
wasted mouse and the MND2 mouse models of motor neuron
disease [34], or the staggered mouse [35], and after experimental
axonal loss [36–38]. Our data support this notion and further
indicate that neuronal defects impede immune-competence
regardless of the time of occurrence. Given the crucial role
for neuronal function in the regulation of central and
peripheral competence, it would be important to deﬁne appro-
priate monitoring and therapeutic options for patients with
neurological dysfunctions likely at risk for immune-incompetence
development.
Figure 6. Mature T cells from double KO mice reveal a naı ¨ve phenotype
and normal proliferative capacities. (A) Rac3
KO and Rac1
N/Rac3
KO mice
were sacriﬁced at P13. Splenocytes were recovered and analysed by
ﬂow cytometry following staining with anti-CD4, CD44, and CD62L
mAbs. The plots are gated on viable CD4
1 T cells. Data from one
representative mouse out of ten analysed are depicted. The frequency
of naı ¨ve (CD44
low, CD62L
high), central memory (CD44
high, CD62L
high),
and effector (CD44
high, CD62L
low) cells is depicted. (B) Splenocytes were
labelled with CFSE and cultured in the absence (Nil) or presence of
CD3/CD28 mAbs. After 5 days cells were stained with anti-CD4 and CD8
mAb and analysed by ﬂow cytometry. Representative histograms
depict viable CD4
1 cells. Similar results were obtained for CD8
1 cells
(data not shown).
Figure 7. Thymic involution in double KO mice reﬂects increased apoptosis. Rac3
KO and Rac1
N/Rac3
KO were sacriﬁced at P13. Cryosections from
the thymus were analysed by hematoxylin and eosin staining, and immunohistochemistry with anti-cleaved caspase 3 (c-Casp3) antibody. Bar:
50mm.
Eur. J. Immunol. 2011. 41: 1410–1419 Veronica Basso et al. 1416
& 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.euMaterials and methods
Mice
Animal care was in accordance with institutional guidelines.
Procedures for the generation of Rac1
N, Rac3
KO, and Rac1
N/
Rac3
KO mice, and for their genotyping have been described [14].
For experiments, Rac1
F/F mice were crossed with Rac1
F/1SynI-
Cre mice to obtain Rac1
F/F and Rac1
F/FSynI-Cre littermates,
deﬁned as WT and Rac1
N respectively; whereas Rac1
F/FRac3
KO
mice were crossed with Rac1
F/1SynI-Cre/Rac3
KO mice to obtain
Rac1
F/F/Rac3
KO and Rac1
F/FSynICre/Rac3
KO littermates, deﬁned
as Rac3
KO and Rac1
N/Rac3
KO respectively.
Antibodies
The following antibodies were used for biochemical and
morphological analysis: anti-calnexin polyclonal antibody (pAb)
(Sigma); anti-tau mAb, anti-choline acetyltransferase (Chemicon
International, Temecula, CA); anti-b3 tubulin (Tuj1, from
Berkeley Antibody Company, Richmond, CA); anti-neuroﬁlament
(Afﬁnity); anti-TH (from Neuromics); anti-Rac3 pAb [13]; anti-
Rac mAb (Upstate Biotechnology, Lake Placid, NY); anti-active
caspase-3 mAb (BD Biosciences, San Jose, CA); anti-CD3e (clone
CT-CD3; Valter Occhiena); anti-cytokeratin 5 (Covance); anti-
cytokeratin 8 and anti-claudin-4 (Zymed), anti-FoxP3
(eBioscience), anti-TdT (DAKO).
Flow cytometry analysis
Mice were sacriﬁced at P4–P13. Thymus, peripheral lymph nodes,
and spleen were collected, and homogenized into single-cell
suspensions. Viable cells were enumerated by Trypan
Blue-assisted counts. The cells were then incubated with a
blocking buffer (5% rat serum and 95% culture supernatant
of 2.4G2 anti-FcR mAb-producing hybridoma cells) for
20min at 41C to saturate the FcRs. Cells were then stained
for CD4, CD8, B220, CD44, CD62L mAb (BD Biosciences).
Thymocyte subpopulations were detected by staining with
Figure 8. Suboptimal thymic innervation in Rac1
N/Rac3
KO double KO mice. (A) Cryosections of the thymus from P13 Rac1
N/Rac3
KO and control
Rac3
KO littermates were stained with anti-TH antibodies and analysed by confocal microscopy (representative images are shown in Supporting
Information Fig. 7). The density of TH
1 ﬁbres was quantiﬁed and expressed as the number of TH
1 ﬁbres per 0.015mm
2 of thymic cortex. Data are
mean7SEM of 80 ﬁelds from eight thymic sections per genotype from three independent experiments. Student t test: p50.24 comparing control
Rac3
KO and Rac1
N/Rac3
KO littermates. (B–E) Tau and calnexin expression was evaluated by immunoblotting thymic lysates (100mg protein per lane;
for each comparison, two distinct pairs of littermates are shown) obtained at (B and C) P13 and (D and E) P9. (C and E) Expression of the major
intermediate band of tau (tau-m) and of total tau (equal to the sum of the signals for all the bands speciﬁcally recognized by the anti-tau antibody)
was normalized to that of calnexin and presented as mean7SEM (n54–5 different thymi per mouse genotype). p o 0.05 by the Student’s t test
comparing control Rac3
KO and Rac1
N/Rac3
KO littermates.
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a FACSCANTO (Becton Dickinson) and then analysed using Flow
Jo software.
When indicated cells were labelled with the vital dye CFSE as
described previously [39], stimulated with plate-bound anti-CD3
(2C11) and anti-CD28 (37.51) mAbs, and analyzed by ﬂow
cytometry.
Histology and immunohistochemistry
Organs isolated from P13 mice were cryosectioned and processed
for diaminobenzidine light or ﬂuorescence confocal immuno-
cytochemistry as described previously [13, 40]. Sections were
were stained with the indicated antibodies and counterstained
with DAPI. Hematoxylin staining was performed on cryosections
with Hematoxylin QS (Vector Labs). Sections were observed
through an Ultraview (PerkinElmer) and a Zeiss upright
microscope with Nomarski optics.
Biochemical analysis
Organs isolated from P9 or P13 mice were lysed with nine
volumes of lysis buffer (0.5–1% Triton X-100, 150mM NaCl,
20mM Tris-Cl, pH 7.5, 1% sodium ﬂuoride, 1% sodium
orthovanadate, cocktail of protease inhibitors). Cleared lysates
were used for immunoblotting and immunoprecipitation
with the indicated antibodies. For the detection of Rac3 in
organs, lysates were incubated with anti-Rac3 antibody
pre-adsorbed to protein A Sepharose beads, washed, and used
for analysis by SDS-PAGE and immunoblotting with anti-Rac
mAb recognizing all Rac proteins (Upstate Biotechnology). The
ﬁrst antibodies were revealed either by
125I-protein A (Amer-
sham) or by HRP-conjugated anti-rabbit or anti-mouse immu-
noglobulins (ECL, Amersham). For the quantiﬁcation of the
protein levels, bands from the immunoblots were analysed
with a Personal SI Laser Densitometer (Molecular Dynamics,
Sunnyvale, CA).
Statistical analysis
Data were analysed by the Student’s t test or by one-way ANOVA
with Bonferroni correction: po0.05; po 0.005; po 0.001
comparing single or double KO with WT mice. Statistically
signiﬁcant differences are indicated in the ﬁgures.
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